Multiple genetic alterations, including concurrent inactivation of RB and p53, occur frequently in several human cancers. To investigate the biological signi®cance of RB and p53 gene inactivations, a wild-type RB or p53 cDNA expression vector regulated by tetracycline was introduced by stable transfection into an osteosarcoma cell line Saos-2, in which both the RB and p53 genes were inactivated. Induction of introduced RB expression resulted in suppression of cell growth, increased percentage of cells at the G 0 /G 1 phase, and enlargement of the cells. Furthermore, activity of alkaline phosphatase was increased and expression of ®bronectin was decreased, suggesting the induction of cell dierentiation by RB expression. Induction of p53 expression also resulted in signi®cant suppression of cell growth with slight accumulation of cells at the G 0 /G 1 and G 2 /M phases. The cells were detached from culture dishes and the dead cell fraction increased. Furthermore, condensation of chromatin and DNA fragmentation were observed, suggesting the induction of apoptosis by p53. These results suggest that RB and p53 play dierent roles in carcinogenesis of osteoblast; RB inactivation releases cells from G 0 /G 1 arrest and suppresses cell dierentiation while p53 inactivation assists the cells to proliferate by repressing both apoptosis and cell cycle arrest at G 0 /G 1 and G 2 /M.
Introduction
Multiple genetic alterations, including inactivations of RB (Benedict et al., 1990; Hollingsworth and Lee, 1991) and p53 (Hollstein et al., 1991; Levine et al., 1991; Nigro et al., 1989) , occur commonly in a variety of human cancers. Both the RB and p53 genes are inactivated in several types of human carcinomas, including osteosarcoma (Diller et al., 1990; Huang et al., 1988) , soft tissue sarcoma (Stratton et al., 1990) , lung cancer (Takahashi et al., 1989; Harbour et al., 1988; Yokota and Sugimura, 1993) , cervical cancer (Schener et al., 1991) , pancreatic cancer (Ruggeri et al., 1992) and hepatocellular carcinoma (Murakami et al., 1991) . RB and p53 proteins are shown to control cell growth and to regulate expression of several dierent genes (Hartwell and Kastan, 1994; Weinberg, 1995; Hollingsworth et al., 1993a,b) . The RB gene is suggested to regulate cell cycle at the G 0 /G 1 phase in several reports (Goodrich et al., 1991; Goodrich and Lee, 1992; Hinds et al., 1992; Gietting et al., 1995) . It is also suggested that the p53 gene regulates cell cycle at the G 0 /G 1 phase (Diller et al., 1990; Mercer et al., 1990; Goodrich and Lee, 1992) or induces apoptosis (Yonish-Rouach et al., 1991; Shaw et al., 1992) . In the pathway of signal transduction for cell cycle control, p53 is located upstream of RB because p53 directly induce p21 WAF1/CIP1 that inhibits RB phosphorylation (El-Deiry et al., 1993; Harper et al., 1993) . If both genes locate in a train of the same signal transduction pathway, the defect in either of the two genes would be enough for carcinogenesis. Therefore, to elucidate the molecular mechanism of multistage human carcinogenesis, it is important to clarify the biological signi®cance of RB and p53 inactivation in cancer cells carrying both gene inactivations.
We previously showed that functional correction of either RB or p53 was sucient to suppress the growth of SCLC cells, in which both RB and p53 were inactivated, and that the p53 gene induced apoptosis but not G 1 arrest (Ookawa et al., 1993; Adachi et al., 1996) . Nonetheless, the detailed function of the RB gene could not be clari®ed since clones with high expression level were not obtained (our unpublished work). An osteosarcoma cell line Saos-2 has been frequently used for the studies on biological function of the p53 and RB genes, because the p53 gene was homozygously deleted and only truncated RB protein was expressed (Diller et al., 1990; Huang et al., 1988) . However, biological eects of RB expression in this cell line were not always consistent among the reports (Huang et al., 1988; Templeton et al., 1991; Qin et al., 1992; Goodrich et al., 1991; Goodrich and Lee, 1992; Hinds et al., 1992; Fung et al., 1993; Zhou et al., 1994) and the same was the case with those of p53 expression (Diller et al., 1990; Chen et al., 1990; Goodrich and Lee, 1992; Buckbinder et al., 1994; Yonish-Rouach et al., 1994 Yamato et al., 1995) . Such dierences in the results would be partly due to the dierences in gene transfer methods, including the potency of expression vectors and the use of temperature sensitive mutant, and arising of variant clones with tumor suppressor resistant (TSR) phenotype (Zhou et al., 1994) . Therefore, in order to clarify the biological function of tumor suppressor genes, it is highly recommended to analyse phenotypic alterations by conditional expression of the wild-type genes. Furthermore, it is also desirable to compare biological eects of the RB and p53 genes using the same vector system in the same carcinoma cells.
Using tetracycline-regulated inducible gene expression system (Gossen and Bujard, 1992) , we cloned several Saos-2 derivatives in which expression of introduced RB and p53 genes was tightly controlled by the tetracycline. Here we demonstrate that both of the RB gene and the p53 gene suppress the growth of Saos-2, but RB induced G 0 /G 1 arrest and differentiation while p53 induced apoptosis, G 0 /G 1 arrest and G 2 / M arrest.
Results
Isolation of osteosarcoma cells that express wild-type RB and p53 RB and p53 inducible Saos-2 cells were established as described below. The tetracycline trans-activator expression vector pTA-Hyg was ®rst transfected into Saos-2 cells and clones with tetracycline trans-activator expression were selected. Then, the RB gene expression vector pT2RBneo and the p53 gene expression vector pT2Xp53neo were transfected into Saos-2 derived STAe cells that express high level of tetracycline transactivator in the absence of tetracycline. A number of G418 resistant clones were isolated, and expression of transfected RB and p53 genes were analysed by Western blotting in the absence of tetracycline; in the induced state of the introduced gene. In several clones, RB or p53 protein was detected and both proteins were undetectable when cultured in the presence of tetracycline; in the repressed state. The results of representative clones are shown in Figure 1a and b.
The amounts of induced RB protein in SRB-1, -3 and -7 cells were similar to each other and equivalent to that of a lung cancer cell line A427, that expresses abundant wild-type RB protein (Ookawa et al., 1993) ( Figure 1a ). The amount of RB protein in SRB-3 reached to the maximum at 24 h of induction and was steady up to 96 h (Figure 1c) . A smeary region above a major 110 kDa band was observed at 12 and 24 h, suggesting the presence of phosphorylated form of the RB protein, whereas it was less at 48 and 96 h. The amounts of p53 protein in Sp53-1, -2 and -3 cells were dierent to each other but were not less than that in a small-cell lung cancer cell line Lu135, which expresses abundant mutant p53 protein (Sameshima et al., 1992) (Figure 1b ). Additional bands with lower molecular weight in Sp53-3 and untransfected Lu135 cells were also detected in Sp53-1 and -2 by overexposure of the blot (data not shown). Those proteins are probably degraded forms of the p53 protein and were not speci®cally detected in transfectants. The amount of p53 protein in Sp53-2 reached to the steady level at 12 h of induction (Figure 1d ). Expression of a wild-type p53-responsive downstream target gene, p21 WAF1/CIP1 (El-Deiry et al., 1993) , was induced in these cells (data not shown).
Eect of wild-type RB and p53 induction on the cell growth and cell morphology Eect of RB and p53 expression on the growth of Saos-2 cells was examined by alamar Blue¯uorescence. Growth rates of SRB-1, -3 and -7 were not signi®cantly changed in 3 days of RB expression but slightly reduced afterwards (Figure 2A ). In contrast, the growth rates of Sp53-1, -2 and -3 were reduced within 2 days of p53 expression ( Figure 2B ). In particular, the cell number was markedly decreased in Sp53-3 in which the amount of p53 protein was the highest among the clones. The growth of control clone SRB-N, that was isolated following transfection of pT2RBneo and was negative for RB expression, was not Alterations in cell morphology were also examined in those RB-and p53-induced clones. All three RBinduced clones became enlarged and¯attened in about 4 days of induction. The morphology of SRB-1 cells at 7 days was shown in Figure 3A and B. On the other hand, all the p53-induced clones showed irregular outline and were detached from culture dishes in 1 to 3 days of p53 expression. The morphology of Sp53-3 at 7 days was shown in Figure 3C and D. The morphology of control clone SRB-N was not altered after depletion of tetracycline. SRB-1, -7, Sp53-2, -3 and SRB-N were used for further analyses.
Eect of wild-type RB and p53 expression on the viability and cell cycle of exponentially growing cells Suppression of cell growth induced by RB or p53 could be a result from induction of cell death or inhibition of cell cycle progression at speci®c phase. Therefore, we ®rst analysed the eects of RB and p53 expression on viability of the cells at 48 h after induction ( Table 1) . The viability was not remarkably changed in SRB-1 and -7 by RB expression, whereas it was signi®cantly decreased in Sp53-2 and -3 by p53 induction. We next analysed alterations in cell cycle distribution of exponentially growing cells by induction of RB or p53 expression (Table 1) appeared too rapid in comparison with that assessed by the growth curves. It might be due to the fact that unsynchronized cells were used for both assays. The cells gradually accumulated at the G 0 /G 1 phase by RB induction, and 20 ± 30 percent of cells were still at the S and G 2 /M phases after 48 h of induction. This might be the reason why the number of cells still continued to increase in the ®rst few days.
To further investigate whether cells were arrested at G 0 /G 1 phase by p53 expression, cells exposed to the induced state for 24 h were treated with nocodazole for additional 24 h to prevent the G 2 /M phase cells from recycling back to the G 0 /G 1 phase (Zieve et al., 1980) and analysed for the DNA content. As shown in Figure 4 , signi®cant numbers of p53 induced cells remained at the G 0 /G 1 phase whereas most of uninduced cells progressed to the G 2 /M phase. Following nocodazole treatment, G 0 /G 1 phase cells became more dominant by RB expression than by p53 expression. DNA contents were not changed by depletion of tetracycline in SRB-N cells. These results suggest that the growth suppression induced by RB expression is due to G 0 /G 1 arrest and that by p53 expression is due to mainly cell death and partly cell cycle arrest at the G 0 /G 1 and G 2 /M phases.
Dierentiation induced by wild-type RB expression and apoptosis induced by wild-type p53 expression To determine whether or not RB-induced cells undergo dierentiation, we analysed alkaline phosphatase activity and ®bronectin expression at 4 days after induction because the former increases and the latter decreases during osteoblast dierentiation (Stein et al., 1990) . In SRB-1 and -7 cells, alkaline phosphatase activity was increased upon RB expression by 43% and 58%, whereas no signi®cant increase was observed in control SRB-N cells, parental STA-e or Saos-2 cells (Table 2) . Furthermore, the ®bronectin protein decreased by RB induction in SRB-1 and -7 cells as compared with the corresponding uninduced cells ( Figure 5 ). On the other hand, alkaline phosphatase activity was decreased in Sp53-2 and Sp53-3 cells by 43% and 48%. It was probably due to the increase of dead cells. These cells were not analysed for ®bronectin expression, since sucient amount of cell lysate was not available by cell death. Therefore, it was suggested that osteosarcoma cells were dierentiated by RB induction.
To examine whether cell death caused by p53 expression was due to apoptosis, we investigated morphology of nuclei and DNA fragmentation (Wyllie et al., 1980; Gavrieli et al., 1992) . In situ staining with Hoechst33258 revealed that a number of Sp53-2 and -3 cells showed condensation and fragmentation of chromatin at 48 h after induction ( Figure 6A ). Furthermore, in situ terminal deoxy nucleotidyl transferase assay (TdT) showed that DNA fragmentation frequently occurred by p53 induction Figure 4 Cell cycle changes in Saos-2 subclones by induction of introduced RB and p53 genes. Cells were incubated in the presence or absence of 1 mg/ml tetracycline (Tc) at 378C for 24 h, then treated with 40 ng/ml nocodazole for additional 24 h, stained for DNA content with propidium iodide and analysed using a¯ow cytometer. but not in p53 repressed state in Sp53-2 and -3 cells. On the other hand, it was not observed in SRB-1, -7 and SRB-N cells. Figure 6B illustrates the results of TdT assay for Sp53-3 (panels a and b) and SRB-1 cells (panels c and d). Therefore, we concluded that apoptosis was induced by p53 expression.
Discussion
In this study, several RB or p53 inducible Saos-2 cells were cloned to assess the biological signi®cance of inactivations of these genes. Expression of the introduced genes was tightly regulated by tetracycline and induced suppression of cell growth in dierent manners. RB expression caused signi®cant G 0 /G 1 arrest and showed no change in cell viability, while p53 expression caused apoptosis as well as G 0 /G 1 and G 2 /M arrest. Furthermore, it was suggested that dierentiation of osteosarcoma cells was induced by RB expression but not by p53 expression. Although we present here the biological characteristics of two RB-inducible clones and two p53-inducible clones, such characteristics were common among various other RB-inducible and p53-inducible clones, including SRB-3 and Sp53-1. Our results in osteosarcoma cells were similar to the result of the previous report that the RB gene controls dierentiation and the p53 gene induces apoptosis during the development of mouse lens (Morgenbesser et al., 1994) . The ®ndings in our study suggested that RB inactivation permits cells to escape from G 1 arrest of cell cycle regulation and from induction of dierentiation, resulting in unregulated growth of undierentiated cells. It is also suggested that p53 inactivation assists cells to grow without apoptosis and without cell cycle arrest at G 0 /G 1 and G 2 /M phases, and results in immortalization. Subsequently these alterations are likely to lead cells to malignant transformation. Thus, it was strongly suggested that inactivation of RB signal transduction pathway collaborates with that of p53 in human carcinogenesis as suggested by the transgenic mouse studies (Symonds et al., 1994; Williams et al., 1994) . A variety of human tumors exhibit p53 inactivation (Hollstein et al., 1991) , while RB inactivation is restricted to a subset of human tumors (Benedict et al., 1990; Horowitz et al., 1990) . However, tumor cells lacking RB inactivation often show abnormalities of genes involved in the RB signal transduction pathway, such as p16 (Okamoto et al., 1994; Koh et al., 1995; Lukas et al., 1995; Kamb et al., 1994; Nobori et al., 1994) , cdk4 (Schmidt et al., 1994; Reifenberger et al., 1994; He et al., 1994) and cyclin D1 (Schussing, 1995) . In addition, RB inactivation is associated with further malignant transformation of cancer cells (Ishikawa et al., 1991; Xu et al., 1991; Presti et al., 1991) . These ®ndings also support collaboration of inactivated RB and p53 pathways in the development of many types of human cancer.
In Saos-2 cells, growth suppression was demonstrated by infection of retrovirus RB expression vector (Huang et al., 1988) and transfection of RB expression vectors (Templeton et al., 1991; Quin et al., 1992) , and G 1 arrest was shown by microinjection of RB protein (Goodrich et al., 1991; Goodrich and Lee, 1992) and transfection of RB expression vector (Hinds et al., 1992) . Thus, our results by RB inducible vector were consistent to those of the previous ones. On the other hand, Zhou et al. (1994) and Fung et al. (1993) demonstrated no remarkable changes in phenotypes of Saos-2 cells by RB expression, suggesting the appearance of clones that gained TSR phenotype. In our study, long-term culture without tetracycline resulted in the appearance of revertant cells. However, the level of RB expression was reduced in the revertant cells and no clone showed TSR phenotypes (data not shown). It has been also suggested that the RB gene regulates cell dierentiation, despite the fact that there are only a few pieces of evidence for this scenario (Weinberg, 1995) . Previously, morphological changes of Saos-2 cells by RB expression was reported by others (Huang et al., 1988; Templeton et al., 1992; Quin et al., 1992) . Therefore, we carefully examined for the possibility that the osteosarcoma cells were dierentiated by RB expression and demonstrated here the evidence for induction of dierentiation, that is, alkaline phosphatase activity was increased and ®bronectin expression was decreased in Saos-2 cells by RB expression. However, we have not obtained the conclusive data that RB expression itself is enough to induce terminal dierentiation in osteogenic sarcoma cells. Thus, it is needless to say that further studies are necessary to elucidate the role of the RB gene in cell dierentiation. It would be also of great interest to know whether or not RB expression is involved in dierentiation in other types of cells. Various phenotypic alterations have been reported to occur in Saos-2 cells by p53 expression; apoptosis by transient transfection of a wild-type p53 expression vector (Yonish-Rouach et al., 1994 , G 1 arrest by microinjection of a p53 expression vector or p53 protein (Diller et al., 1990; Goodrich and Lee, 1992) , and G 1 and G 2 /M arrest by expression of a temperaturesensitive p53 mutant (Yamato et al., 1995) . Furthermore, reduction but not abolishment of cell growth was shown by expression of another dierent temperaturesensitive p53 mutant (Buckbinder et al., 1994) and by infection of retrovirus p53 expression vector (Chen et al., 1990) . These ®ndings suggest that expression of the p53 gene have diverse eects on the phenotypic alterations in Saos-2 cells. It is noted that all phenomena described separately were observed in our study by induction of relatively high amounts of p53 protein. It is likely that the potency of wild-type p53 activity, such as the amount of p53 protein and properties of temperature-sensitive mutants, would be critical to induce each of those phenotypic alterations.
In this study, the proportion of G 0 /G 1 phase cells was not increased by p53 expression itself (Table 1) , although p53 expression induced decrease of S phase cells and increase of G 2 /M phase cells along with apoptosis. In contrast, nocodazole treatment revealed accumulation of the G 0 /G 1 phase cells. These ®ndings suggest that cells at the G 0 /G 1 phase were diminished by G 2 /M arrest and/or by apoptosis of the cells at the G 0 /G 1 phase. Therefore, it is possible that G 1 arrest by p53 could be detected under speci®c culture conditions. G 2 /M arrest by p53 was also suggested by recent studies (Cross et al., 1995; Agarwal et al., 1995; Yamato et al., 1995; Stewart et al., 1995) , while it is not well understood whether apoptosis occurs in cells at speci®c phase by p53 expression. Present results also suggest that RB is not always necessary for induction of G 1 arrest by p53, although one of the pathways for p53-mediated cell growth control is considered to be regulation of RB phosphorylation through the induction of a cycline-CDK inhibitor p21 WAF1/CIP1 (El-Deiry et al., 1993; Harper et al., 1993) . Further investigations are necessary to clarify these issues.
Materials and methods

Plasmids
Plasmid pTA-Hyg (Adachi et al., 1996 ) is a tet repressorherpes simplex virus trans-activator protein VP16 (tTA) fusion-protein expression construct, which was generated by ligating a hygromycin-resistant gene from pHyg to pUHD15-1 (Gossen et al., 1992) . Plasmid pT2GN is a tTA responsive b-galactosidase reporter construct generated by subcloning the cDNA encoding b-galactosidase from SVgal (Promega) and the neomycin-resistant gene from pcDNAIneo into a tTA-responsive expression vector pT2 (Adachi et al., 1996) derived from pUHD10-3 (Gossen et al., 1992) . Plasmids pT2Xp53neo (Adachi et al., 1996) and pT2RBneo were constructed by subcloning the wild-type p53 cDNA from php53B (Zakut-Houri et al., 1985) and the wild-type RB cDNA from p7ZFSS into pT2, respectively, in addition to the ligation of the neomycin-resistant gene. Recombinant RB and p53 cDNAs were con®rmed as wild-type by DNA sequencing.
Cell culture and transfection
The human osteosarcoma cell line Saos-2 was grown in Dulbecco's modi®ed Eagle's medium (Nissui) supplemented with 10% heat inactivated fetal calf serum in a 5% CO 2 incubator at 378C. Saos-2 cells were ®rst transfected with pTA-Hyg by lipofectoamine according to manufacturer's protocol (GibcoBRL-Life Technologies). Cells were selected in medium containing hygromycin B (0.3 mg/ml, Calbiochem) in the absence of tetracycline. Hygromycinresistant clones were tested for expression of tetracyclineresponsive trans-activator by transient transfection with pT2GN in the presence or absence of 1 mg/ml tetracycline and subsequent standard b-galactosidase assay (Sambrook et al., 1989) . A tTA expression clone was next transfected with pT2RBneo or pT2Xp53neo. Cells were selected in medium containing hygromycin B and G418 (0.5 mg/ml, GibcoBRL-Life Technologies) in the presence of 1 mg/ml tetracycline. Hygromycin-and G418-resistant colonies were cloned, subsequently maintained in the culture medium containing hygromycin B and G418 with 1 mg/ml tetracycline and expanded for further analyses.
Western blotting
Cells were lysed with lysis buer (50 mM HEPES-NaOH, pH 7.0, containing 0.1% Nonidet P-40, 250 mM NaCl, 5 mM EDTA, 50 mM NaF, 1 mM dithiothreitol, 50 mg of aprotinin per ml, and 1 mM phenylmethylsulfonyl¯uoride for RB and p53, 40 mM HEPES-NaOH, pH 7.0, containing 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 150 mM NaCl, 5 mM EDTA, 1 mM dithiothreitol, 50 mg of aprotinin per ml, and 1 mM phenylmethylsulfonyl¯uoride for ®bronectin). Fifty mg of total protein were separated in a 8% or 5% SDS-polyacrylamide gel and electroblotted to Hybond-ECL nitrocellulose membrane (Amersham). Equal loading of protein was con®rmed by staining the membrane after detection. After blocking with 4% nonfat dry milk in Tris-buered saline, membranes were incubated for 2 h with the anti-RB monoclonal antibody PMG3-245 (Pharmingen), the anti-p53 monoclonal antibody PAb1801 (Oncogene Science) or the anti-®bronectin monoclonal antibody FN30-8 (Takara). The blot was then probed by the ECL Western blotting detection system (Amersham).
Cell growth measurement
Cell number of Saos-2-derived clones was examined by the alamar Blue assay (IWAKI). Equal numbers of cells from individual clones were seeded in 96 well plates at the density of 5610 2 cells per well and cultured with 100 ml of culture medium in the presence or absence of 1 mg/ml tetracycline. At each time point, 10 ml of alamar Blue was added and the cells were incubated in a 5% CO 2 incubator at 378C for 3 h. Subsequently,¯uorescence of each well was measured with excitation wavelength at 544 nm and emission at 590 nm using a¯uorometer (Fluoroskan II, Flow laboratory). It was also con®rmed that the reaction proceeded linearly within the range of 5610 ± 2610 3 uorescence intensity corresponding to 1610 3 ± 1610 4 viable cells in a well.
Cell cycle and cell viability analyses
Subcon¯uent cells of Saos-2 derived clones were trypsinized and replated at a 1:2-4 split ratio in culture medium with and without tetracycline. To determine cell viability, cells were harvested and resuspended in DMEM supplemented with 10% FCS and stained with 50 mg/ml propidium iodide and 60 mM¯uorescein diacetate (FDA, Sigma) for 10 ± 20 min at 378C (Jones and Senft, 1985) . Subsequently, two-parameter analysis was performed on a Becton-Dickinson FACScan¯ow cytometer. On a twodimensional plot of FDA versus propidium iodide, cells were separated into two populations: viable cells with high FDA¯uorescence and low propidium iodide¯uorescence, and dead cells with low FDA. The dead cells were further divided into two populations with high and low propidium iodide¯uorescence.
For replicative DNA synthesis, cells incubated with 10 mM BrdU (Sigma) for 30 min at 48 h after induction were treated with anti-BrdU antibody (Becton Dickinson) followed bȳ uorescein isothiocyanate (FITC)-conjugated anti-mouse Ig antibody (Dako). These cells were also stained with propidium iodide for DNA content (Molecular Probes). Two-parameter analysis was carried out with the¯ow cytometer and the proportions of cells in G 0 /G 1 , S, and G 2 / M phases of the cell cycle were determined. To observe the progression of cells through G 0 /G 1 to G 2 /M, nocodazole (Aldrich) was added to a ®nal concentration of 40 ng/ml at 24 h after induction and the cells were incubated for additional 24 h to arrest cells in mitosis (Zieve et al., 1980) . The cells were stained with propidium iodide in the presence of RNase A (Amresco) and analysed for DNA contents by the¯ow cytometer.
Alkaline phosphatase assay
Cells were washed three times with Tris-buered saline (50 mM Tris-HCl, pH7.8, containing 140 mM NaCl), scraped into 10 mM Tris-HCl, pH 7.8, and sonicated. Each lysate was used as enzyme source. Alkaline phosphatase activity was assayed with p-nitrophenyl phosphate as a substrate using a kit (Wako). Protein content was measured by the Coomassie blue protein assay (Bio-Rad Laboratories). Enzymatic activity was expressed as nanomoles per min/mg protein.
Apoptosis assay
Apoptotic cells were detected by in situ Hoechst33258 staining. Cells grown on slide glass were ®xed in 4% paraformaldehyde/phosphate buered saline and incubated with 0.075 mg/ml Hoechst33258 (Calbiochem) for 30 min at room temperature. Apoptotic cells were identi®ed by their condensed or fragmented chromatin with a¯uorescene microscope. DNA fragmentation was examined by terminal deoxy transferase assay using a in situ cell death detection kit (Boehringer Mannheim) according to manufacturer's instructions.
